Western pharmaceutical companies began to sell fewer drugs in Russia
Over the two years since the Russian-Ukrainian military conflict, the American pharmaceutical company MSD has reduced its portfolio of drugs...
Over the two years since the Russian-Ukrainian military conflict, the American pharmaceutical company MSD has reduced its portfolio of drugs...
Since pre-pandemic 2019, the Russian pharmaceutical market has grown by 60%, and over ten years - 2.5 times. This dynamics...
-->-->-->--> Source link
The expert community is asking the Federal Antimonopoly Service (FAS) to assist in issuing a compulsory license for dolutegravir, an...
-->-->-->--> Source link
The hope that pharmaceutical companies from China and India will replace modern drugs from Western manufacturers on the Russian market...
While the inheritance dispute over the generic drug manufacturer Canonpharma Production continues after the death of its founder Merab Kokeladze,...
The fact that the Danish Novo Nordisk has a patent for the popular drug for controlling glucose levels “Ozempic” did...
-->-->-->--> Source link
Along with the gradual withdrawal of international pharmaceutical holdings from the clinical research market, foreign contract research companies (CROs) also...
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
One of the most popular antiviral drugs in Russia, Ingavirin from Valenta Pharm, included in the treatment protocols for coronavirus,...
While international pharmaceutical manufacturers have noticeably reduced clinical trials of drugs in Russia, the R-Pharm company founded by Alexey Repik...
As an analysis by Kommersant showed, over the three quarters of 2023, Russian pharmaceutical manufacturers received 12% more approvals for...
The emergence of a large number of generics of lenalidomide for the treatment of multiple myeloma instead of the original...